Systematic overview of the pharmacological management of postherpetic neuralgia: An evaluation of the clinical value of critically selected drug treatments based on efficacy and safety outcomes from randomized controlled studies

Dermatology

Volumn 208, Issue 3, 2004, Pages 206-216

  Plaghki, L ^a   Adriaensen, H ^c   Morlion, B ^d   Lossignol, D ^b   Devulder, J ^e  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d Universitair Ziekenhuis   (Belgium)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Herpes zoster; Pain treatment; Postherpetic neuralgia; Randomized clinical trials; Systematic review

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; DESIPRAMINE; FLUPHENAZINE; GABAPENTIN; LORAZEPAM; MAPROTILINE; NORTRIPTYLINE;

CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONSTIPATION; DEPRESSION; DIARRHEA; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HEART PALPITATION; HERPES ZOSTER; HUMAN; INSOMNIA; LETHARGY; MICTURITION DISORDER; MOOD DISORDER; PAIN; PERIPHERAL EDEMA; POPULATION RESEARCH; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; STANDARDIZATION; WEIGHT GAIN; XEROSTOMIA;

ANALGESICS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; HERPES ZOSTER; HUMANS; NEURALGIA;

EID: 2342655028     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077301     Document Type: Review

References (28)

1. Johnson RW: Herpes zoster and postherpetic neuralgia: Optimal treatment. Drugs Aging 1997;10:80-94.
2. Jensen TS, Gottrup H, Sindrup SH, Bach FW: The clinical picture of neuropathic pain. Eur J Pharmacol 2001;429:1-11.
3. Lancaster T, Silagy C, Gray S: Primary care management of acute herpes zoster: Systematic review of evidence from randomized controlled trials. Br J Gen Pract 1995;45:39-45.
4. Kishore-Kumar R, Max MB, Schafer SC, Gaughan AM, Smoller B, Gracely RH, Dubner R: Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990;47:305-312.
5. Bonezzi C, Demartini L: Treatment options in postherpetic neuralgia. Acta Neurol Scand Suppl 1999;173:25-35.
6. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH: Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988;38:1427-1432.
7. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L: Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998;280:1837-1842.
8. Kupers RC, Konings H, Adriaensen H, Gybels JM: Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain 1991;47:5-12.
9. Rumsfield JA, West DP: Topical capsaicin in dermatologic and peripheral pain disorders. DICP Ann Pharmacother 1991;25:381-387.
10. Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E: A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993;15:510-526.
11. Attal N: Pharmacologic treatment of neuropathic pain. Acta Neurol Belg 2001;101:53-64.
12. Rice AS, Maton S: Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 2001;94:215-224.
13. Field MJ, Hughes J, Singh L: Further evidence for the role of the alpha(2)delta subunit of voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol 2000;131:282-286.
14. Graff-Radford SB, Shaw LR, Naliboff BN: Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain 2000;16:188-192.
15. Bowsher D: The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: A randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 1997;13:327-331.
16. Watson CP, Vernich L, Chipman M, Reed K: Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial. Neurology 1998;51:1166-1171.
17. Gracely RH, McGrath P, Dubner R: Ratio scales of sensory and affective verbal pain descriptors. Pain 1978;5:5-18.
18. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J: Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982;32:671-673.
19. Watson CP, Chipman M, Reed K, Evans RJ, Birkett N: Amitriptyline versus maprotiline in postherpetic neuralgia: A randomized, doubleblind, crossover trial. Pain 1992;48:29-36.
20. Bowsher D: The effects of acyclovir therapy for herpes zoster on treatment outcome in postherpetic neuralgia: A randomised study. Eur J Pain 1994;15:9-12.
21. Bhala BB, Ramamoorthy C, Bowsher D, Yelnoorker KN: Shingles and post-herpetic neuralgia. Clin J Pain 1988;4:169-174.
22. Collins SL, Moore RA, McQuay HJ, Wiffen P: Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review. J Pain Symptom Manage 2000;20:449-458.
23. Sindrup SH, Jensen TS: Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 1999;83:389-400.
24. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A: Anticonvulsant drugs for management of pain: A systematic review. BMJ 1995;311:1047-1052.
25. Watson CP: The treatment of neuropathic pain: Antidepressants and opioids. Clin J Pain 2000;16:S49-S55.
26. Backonja MM: Anticonvulsants (antineuropathics) for neuropathic pain syndromes. Clin J Pain 2000;16:S67-S72.
27. Fields HL, Rowbotham M, Baron R: Postherpetic neuralgia: Irritable nociceptors and deafferentation. Neurobiol Dis 1998;5:209-227.
28. Rowbotham MC, Lottrup Petersen K, Fields H: Is postherpetic neuralgia more than one disorder? Pain Forum 1998;7:231-237.